Literature DB >> 20211303

Myocardial structure and function by echocardiography in relation to glucometabolic status in elderly subjects from 2 population-based cohorts: a cross-sectional study.

Margret Leosdottir1, Ronnie Willenheimer, Jonathan Plehn, Rasmus Borgquist, Petri Gudmundsson, Tamara B Harris, Lenore J Launer, Halldora Bjornsdottir, Peter M Nilsson, Vilmundur Gudnason.   

Abstract

BACKGROUND: Left ventricular (LV) diastolic dysfunction has been associated with impaired glucometabolic status. However, studies of older subjects are lacking. We examined associations between echocardiographic indices of LV diastolic function and LV mass index (LVMI) and glucometabolic status among middle-aged and elderly subjects free from heart disease, hypothesizing that the associations would be comparative to younger cohorts.
METHODS: We examined the Age Gene/Environment Susceptibility Reykjavik Study (Iceland; n = 607, 76 +/- 6 years) and the Malmö Preventive Project Re-Examination Study (MPP-RES) cohorts (Sweden; n = 1,519, 67 +/- 6 years), evaluating associations with multivariable regression analysis.
RESULTS: In the Age Gene/Environment Susceptibility Reykjavik Study, LVMI was positively correlated with glycosylated hemoglobin (HbA1c) (P = .001). Otherwise, echocardiographic variables were not associated with glucometabolic status. In the MPP-RES, LVMI increased with increasing glucometabolic disturbance among both older (70-80 years) and middle-aged (57-69 years) subjects. Among older subjects, HbA1c was positively correlated with 2 variables reflecting LV diastolic function: late transmitral peak flow velocity (A) (P = .001) and early transmitral peak flow velocity (E)/early diastolic peak tissue velocity (Em) (P = .046). In middle-aged MPP-RES subjects, increasing glucometabolic disturbance was correlated with increasing late diastolic peak tissue velocity (Am) (P = .002) and, after age adjustment, with increasing A (P = .001) and decreasing Em/Am (P = .009). With age adjustment, Am and A were positively correlated with fasting glucose and HbA1c.
CONCLUSIONS: Contrary to our hypothesis, in 2 independent cohorts of older individuals, associations between glucometabolic status and LV diastolic function were generally weak. These contrast with previous reports, as well as with observations among middle-aged subjects in the present study. Changes in LV diastolic function may be more age-related than associated with glucose metabolism in older subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211303      PMCID: PMC3242727          DOI: 10.1016/j.ahj.2009.12.028

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  25 in total

1.  Impaired glucose tolerance as a determinant of early deterioration of left ventricular diastolic function in middle-aged healthy subjects.

Authors:  H Okura; H Inoue; M Tomon; S Nishiyama; T Yoshikawa; K Yoshida; J Yoshikawa
Journal:  Am J Cardiol       Date:  2000-03-15       Impact factor: 2.778

2.  Relationship of left ventricular mass to insulin sensitivity and body mass index in healthy individuals.

Authors:  Haksun Ebinç; Fatma Ayerden Ebinç; Zübeyde Nur Ozkurt; Tolga Doğru; Murat Yilmaz
Journal:  Acta Cardiol       Date:  2006-08       Impact factor: 1.718

3.  Impaired glucose tolerance: a possible contributor to left ventricular hypertrophy and diastolic dysfunction.

Authors:  Masashi Fujita; Hiroshi Asanuma; Jiyoong Kim; Yulin Liao; Akio Hirata; Osamu Tsukamoto; Tetsuo Minamino; Masatsugu Hori; Moritaka Goto; Koichi Node; Masafumi Kitakaze
Journal:  Int J Cardiol       Date:  2006-08-24       Impact factor: 4.164

4.  Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity.

Authors:  G Berglund; P Nilsson; K F Eriksson; J A Nilsson; B Hedblad; H Kristenson; F Lindgärde
Journal:  J Intern Med       Date:  2000-01       Impact factor: 8.989

5.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics.

Authors:  Tamara B Harris; Lenore J Launer; Gudny Eiriksdottir; Olafur Kjartansson; Palmi V Jonsson; Gunnar Sigurdsson; Gudmundur Thorgeirsson; Thor Aspelund; Melissa E Garcia; Mary Frances Cotch; Howard J Hoffman; Vilmundur Gudnason
Journal:  Am J Epidemiol       Date:  2007-03-10       Impact factor: 4.897

6.  Determinants of subclinical diabetic heart disease.

Authors:  Z Y Fang; R Schull-Meade; M Downey; J Prins; T H Marwick
Journal:  Diabetologia       Date:  2005-01-08       Impact factor: 10.122

7.  Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging.

Authors:  Nikolay P Nikitin; Klaus K A Witte; Simon D R Thackray; Ramesh de Silva; Andrew L Clark; John G F Cleland
Journal:  J Am Soc Echocardiogr       Date:  2003-09       Impact factor: 5.251

Review 8.  Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.

Authors:  Sajad A Hayat; Billal Patel; Rajdeep S Khattar; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2004-12       Impact factor: 6.124

9.  Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.

Authors:  Martin K Rutter; Helen Parise; Emelia J Benjamin; Daniel Levy; Martin G Larson; James B Meigs; Richard W Nesto; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 10.  A practical approach to the echocardiographic evaluation of diastolic function.

Authors:  Samer J Khouri; George T Maly; David D Suh; Thomas E Walsh
Journal:  J Am Soc Echocardiogr       Date:  2004-03       Impact factor: 5.251

View more
  16 in total

1.  Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort.

Authors:  Kénora Chau; Nicolas Girerd; Martin Magnusson; Zohra Lamiral; Erwan Bozec; Ludovic Merckle; Margret Leosdottir; Erasmus Bachus; Zied Frikha; João Pedro Ferreira; Jean-Pierre Després; Patrick Rossignol; Jean-Marc Boivin; Faiez Zannad
Journal:  Clin Res Cardiol       Date:  2018-04-21       Impact factor: 5.460

2.  Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project.

Authors:  Johan Korduner; Hannes Holm; Amra Jujic; Olle Melander; Manan Pareek; John Molvin; Lennart Råstam; Ulf Lindblad; Bledar Daka; Margret Leosdottir; Peter M Nilsson; Erasmus Bachus; Michael H Olsen; Martin Magnusson
Journal:  Cardiovasc Diabetol       Date:  2022-07-02       Impact factor: 8.949

3.  Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik.

Authors:  A J van Ballegooijen; M Visser; M F Cotch; A E Arai; M Garcia; T B Harris; L J Launer; G Eiríksdóttir; V Gudnason; I A Brouwer
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

4.  The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: a cross-sectional analysis within the Malmö Preventive Project.

Authors:  Margret Leosdottir; Ronnie Willenheimer; Margaretha Persson; Peter M Nilsson
Journal:  Cardiovasc Diabetol       Date:  2011-12-28       Impact factor: 9.951

5.  The Early-Onset Myocardial Infarction Associated PHACTR1 Gene Regulates Skeletal and Cardiac Alpha-Actin Gene Expression.

Authors:  Annina Kelloniemi; Zoltan Szabo; Raisa Serpi; Juha Näpänkangas; Pauli Ohukainen; Olli Tenhunen; Leena Kaikkonen; Elina Koivisto; Zsolt Bagyura; Risto Kerkelä; Margret Leosdottir; Thomas Hedner; Olle Melander; Heikki Ruskoaho; Jaana Rysä
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

6.  A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population--the Malmö preventive project study.

Authors:  Amra Jujić; Margret Leosdottir; Gerd Östling; Petri Gudmundsson; Peter M Nilsson; Olle Melander; Martin Magnusson
Journal:  BMC Med Genet       Date:  2013-06-24       Impact factor: 2.103

7.  Hyperglycemia has a greater impact on left ventricle function in South Asians than in Europeans.

Authors:  Chloe M Park; Therese Tillin; Katherine March; Arjun K Ghosh; Siana Jones; Andrew Wright; John Heasman; Darrel Francis; Naveed Sattar; Jamil Mayet; Nish Chaturvedi; Alun D Hughes
Journal:  Diabetes Care       Date:  2013-11-15       Impact factor: 19.112

8.  Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography.

Authors:  Line Reinholdt Pedersen; Anna Meta Dyrvig Kristensen; Søren Sandager Petersen; Muthiah Vaduganathan; Deepak L Bhatt; Jacob Juel; Christina Byrne; Margrét Leósdóttir; Michael H Olsen; Manan Pareek
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-19       Impact factor: 3.738

9.  WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function.

Authors:  Anne-Mari Moilanen; Jaana Rysä; Leena Kaikkonen; Teemu Karvonen; Erja Mustonen; Raisa Serpi; Zoltán Szabó; Olli Tenhunen; Zsolt Bagyura; Juha Näpänkangas; Pauli Ohukainen; Pasi Tavi; Risto Kerkelä; Margrét Leósdóttir; Björn Wahlstrand; Thomas Hedner; Olle Melander; Heikki Ruskoaho
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

10.  Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study.

Authors:  Mette Lundgren Nielsen; Manan Pareek; Oke Gerke; Margrét Leósdóttir; Peter M Nilsson; Michael Hecht Olsen
Journal:  BMC Cardiovasc Disord       Date:  2015-12-10       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.